Reşit Yiğit Yılancıoğlu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Reşit Yiğit Yılancıoğlu has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Oguzhan Ekrem Turan
Department of Cardiology, Faculty of Medicine, Dokuz Eylül University, İzmir, Türkiye
15 shared publications - Emin Evren Ozcan
Department of Cardiology, Faculty of Medicine, Dokuz Eylül University, İzmir, Türkiye
11 shared publications Emin Evren Özcan
9 shared publications- Ahmet Anıl Başkurt
Department of Cardiology Bakırçay University Izmir Turkey
6 shared publications Oğuzhan Ekrem Turan
Heart Rhythm Management Center, Faculty of Medicine, Dokuz Eylul University, Balcova, Izmir, Turkiye
5 shared publications- Mustafa Eray Kilic
Department of Cardiology, Faculty of Medicine, Dokuz Eylül University, İzmir, Türkiye
4 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 6 (5)
Sex-based differences in the management and outcomes of oesophageal fistula following atrial fibrillation ablation: a subanalysis of the worldwide POTTER-AF study
Aims: Oesophageal fistula (OF) is a rare but life-threatening complication of atrial fibrillation (AF) ablation. Data on sex-related differences in its management and outcomes are limited. Methods and results: The PrOgnosis following oesophageal fisTula formaTion in patients undergoing cathetER ablation for AF study is a global, multicentre study evaluating the incidence, management, and outcome of OF following AF ablation. Among 553 729 patients treated across 214 centres in 35 countries between 1996 and 2022, 138 developed OF. Sex-specific data on management and outcome were available in 117 cases and are analysed herein. Females comprised 47% of the analysed cohort. Baseline characteristics, ablation modality, and use of oesophageal temperature monitoring were not different between sexes in patients developing OF. Fewer women received proton pump inhibitors post-procedure (64.8% vs. 84.7%; P = 0.017). Among patients with OF, less women developed atrio-OF (90.9% vs. 100%; P = 0.021). Oesophageal perforation and oesophageal–pericardial fistula occurred exclusively in females. The median duration until symptoms onset was 20 days for women and 16.5 days for men (P = 0.14). Echocardiography was more frequently used in women (36.4% vs. 15%; P = 0.01). Stroke was more common in women (32.7% vs. 14.8%; P = 0.040), however only before adjusting for potential cofounders. Other complications were comparable. Women underwent endoscopic therapy more often (35.8% vs. 17.7%; P = 0.034) and surgical treatment alone less frequently (28.3% vs. 51.6%; P = 0.014). Fatality rates were high and not different (63.6% in women vs. 67.2% in men; P = 0.70). Conclusion: While OF incidence for each sex could not be calculated, nearly half of all patients with OF were female. Women underwent more often endoscopic and less often surgical interventions; outcomes were comparable.
- 1 September 2026
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 6 (5)
Open AccessSex-based differences in the management and outcomes of oesophageal fistula following atrial fibrillation ablation: a subanalysis of the worldwide POTTER-AF study
Aims: Oesophageal fistula (OF) is a rare but life-threatening complication of atrial fibrillation (AF) ablation. Data on sex-related differences in its management and outcomes are limited. Methods and results: The PrOgnosis following oesophageal fisTula formaTion in patients undergoing cathetER ablation for AF study is a global, multicentre study evaluating the incidence, management, and outcome of OF following AF ablation. Among 553 729 patients treated across 214 centres in 35 countries between 1996 and 2022, 138 developed OF. Sex-specific data on management and outcome were available in 117 cases and are analysed herein. Females comprised 47% of the analysed cohort. Baseline characteristics, ablation modality, and use of oesophageal temperature monitoring were not different between sexes in patients developing OF. Fewer women received proton pump inhibitors post-procedure (64.8% vs. 84.7%; P = 0.017). Among patients with OF, less women developed atrio-OF (90.9% vs. 100%; P = 0.021). Oesophageal perforation and oesophageal–pericardial fistula occurred exclusively in females. The median duration until symptoms onset was 20 days for women and 16.5 days for men (P = 0.14). Echocardiography was more frequently used in women (36.4% vs. 15%; P = 0.01). Stroke was more common in women (32.7% vs. 14.8%; P = 0.040), however only before adjusting for potential cofounders. Other complications were comparable. Women underwent endoscopic therapy more often (35.8% vs. 17.7%; P = 0.034) and surgical treatment alone less frequently (28.3% vs. 51.6%; P = 0.014). Fatality rates were high and not different (63.6% in women vs. 67.2% in men; P = 0.70). Conclusion: While OF incidence for each sex could not be calculated, nearly half of all patients with OF were female. Women underwent more often endoscopic and less often surgical interventions; outcomes were comparable.
- 9 March 2026
- Published by Turkiye Kalp Ve Saglik Vakfi Iktisadi Isletmesi in Journal of Updates in Cardiovascular Medicine
Prevalence and Clinical Relevance of Extracardiac Findings on Preprocedural Computed Tomography Angiography for Catheter Ablation of Atrial Fibrillation
Prevalence and Clinical Relevance of Extracardiac Findings on Preprocedural Computed Tomography Angiography for Catheter Ablation of Atrial Fibrillation - Journal of Updates in Cardiovascular Medicine
- 9 March 2026
- Published by Turkiye Kalp Ve Saglik Vakfi Iktisadi Isletmesi in Journal of Updates in Cardiovascular Medicine
Prevalence and Clinical Relevance of Extracardiac Findings on Preprocedural Computed Tomography Angiography for Catheter Ablation of Atrial Fibrillation
Prevalence and Clinical Relevance of Extracardiac Findings on Preprocedural Computed Tomography Angiography for Catheter Ablation of Atrial Fibrillation - Journal of Updates in Cardiovascular Medicine
- 23 January 2026
- Published by Elsevier in Heart Rhythm
- Vol. 23 (8) , e1453-e1464
Hemolysis and renal safety of pulsed-field vs thermal ablation for atrial fibrillation: A systematic review and meta-analysis
- 23 January 2026
- Published by Elsevier in Heart Rhythm
- Vol. 23 (8) , e1453-e1464
Hemolysis and renal safety of pulsed-field vs thermal ablation for atrial fibrillation: A systematic review and meta-analysis
- 6 January 2026
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (3) , 321-323
GLP-1 receptor agonist therapy is associated with reduced atrial fibrillation recurrence after catheter ablation: a meta-analysis
- 6 January 2026
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (3) , 321-323
GLP-1 receptor agonist therapy is associated with reduced atrial fibrillation recurrence after catheter ablation: a meta-analysis
- 9 November 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 107 (1) , 231-238
Clinical Characteristics and In‐Hospital Prognosis of Myocardial Infarction With Nonobstructive Coronary Arteries in a Single‐Center Experience
Background: Myocardial infarction with nonobstructive coronary arteries (MINOCA) is a heterogeneous syndrome presenting as acute infarction despite < 50% epicardial stenosis. Recognition remains low, and optimal management is unclear. Aims: This study aims to analyze the clinical profile of MINOCA patients compared to those with myocardial infarction with obstructive lesions, and evaluate MINOCA patients. Methods: A total of 1421 consecutive patients with acute MI admitted to our hospital between January 2016 and March 2019 were retrospectively screened. Patients were classified into two groups: MINOCA, comprising patients with no significant lesions on angiography, and MI‐CAD, consisting of patients with lesions of the coronary artery. A total of 130 patients with MINOCA and 210 patients with MI‐CAD were enrolled. Demographics, laboratory parameters, imaging findings, etiologies, in‐hospital outcomes, and discharge therapies were analyzed. Results: The prevalence of MINOCA was 9.7%. Patients with MINOCA were more frequently women (especially premenopausal women) and had a younger age (54.65 ± 18.4 to 63.2 ± 12.3, p < 0.001). The prevalence of traditional CAD risk factors was lower in MINOCA patients. Patients with MINOCA were more likely to have a history of upper‐respiratory‐tract infections (URIs) and use of antidepressant drugs compared to MI‐CAD at admission. In‐hospital mortality and event rates were comparable to those with MI‐CAD. However, antiplatelets, statins, renin−angiotensin system blockers, and β‐blockers were less frequently prescribed to patients with MINOCA at discharge. Conclusions: Patients with MINOCA constitute a population that differs from the classical MI profile. Compared with MI‐CAD, MINOCA is accompanied by fewer traditional risk factors for CAD.
- 9 November 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 107 (1) , 231-238
Clinical Characteristics and In‐Hospital Prognosis of Myocardial Infarction With Nonobstructive Coronary Arteries in a Single‐Center Experience
Background: Myocardial infarction with nonobstructive coronary arteries (MINOCA) is a heterogeneous syndrome presenting as acute infarction despite < 50% epicardial stenosis. Recognition remains low, and optimal management is unclear. Aims: This study aims to analyze the clinical profile of MINOCA patients compared to those with myocardial infarction with obstructive lesions, and evaluate MINOCA patients. Methods: A total of 1421 consecutive patients with acute MI admitted to our hospital between January 2016 and March 2019 were retrospectively screened. Patients were classified into two groups: MINOCA, comprising patients with no significant lesions on angiography, and MI‐CAD, consisting of patients with lesions of the coronary artery. A total of 130 patients with MINOCA and 210 patients with MI‐CAD were enrolled. Demographics, laboratory parameters, imaging findings, etiologies, in‐hospital outcomes, and discharge therapies were analyzed. Results: The prevalence of MINOCA was 9.7%. Patients with MINOCA were more frequently women (especially premenopausal women) and had a younger age (54.65 ± 18.4 to 63.2 ± 12.3, p < 0.001). The prevalence of traditional CAD risk factors was lower in MINOCA patients. Patients with MINOCA were more likely to have a history of upper‐respiratory‐tract infections (URIs) and use of antidepressant drugs compared to MI‐CAD at admission. In‐hospital mortality and event rates were comparable to those with MI‐CAD. However, antiplatelets, statins, renin−angiotensin system blockers, and β‐blockers were less frequently prescribed to patients with MINOCA at discharge. Conclusions: Patients with MINOCA constitute a population that differs from the classical MI profile. Compared with MI‐CAD, MINOCA is accompanied by fewer traditional risk factors for CAD.
- 7 October 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (12) , 3249-3260
Fluoroscopy Integration Module Enhanced Localization of Intramural Premature Ventricular Complex in Ethanol Ablation
Aims: The Fluoroscopy Integration Module (FIM) is a novel feature in electroanatomic mapping systems that enhances real‐time visualization of coronary venous anatomy during mapping and ablation of intramural premature ventricular complexes (PVCs). This report demonstrates the clinical utility of FIM in guiding side branch vein selection and precise ethanol ablation targeting for intramural PVCs. Methods and Results: The target venous branch was selected under FIM guidance in patients with intramural PVCs where RF ablation failed. Ethanol was applied to the venous branch extending to the center of the intersection of ablation tags or early activation areas where transient suppression occurred. Conclusion: The fluoroscopy integration module significantly improves procedural precision in targeting intramural PVCs, facilitating effective ethanol ablation and optimizing clinical success.
- 7 October 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (12) , 3249-3260
Fluoroscopy Integration Module Enhanced Localization of Intramural Premature Ventricular Complex in Ethanol Ablation
Aims: The Fluoroscopy Integration Module (FIM) is a novel feature in electroanatomic mapping systems that enhances real‐time visualization of coronary venous anatomy during mapping and ablation of intramural premature ventricular complexes (PVCs). This report demonstrates the clinical utility of FIM in guiding side branch vein selection and precise ethanol ablation targeting for intramural PVCs. Methods and Results: The target venous branch was selected under FIM guidance in patients with intramural PVCs where RF ablation failed. Ethanol was applied to the venous branch extending to the center of the intersection of ablation tags or early activation areas where transient suppression occurred. Conclusion: The fluoroscopy integration module significantly improves procedural precision in targeting intramural PVCs, facilitating effective ethanol ablation and optimizing clinical success.
- Open Access
- 8 May 2025
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 11 (7) , 689-692
How narrow is narrow QRS in premature ventricular contractions? A novel variant of SCN5A-associated MEPPC
- 8 May 2025
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 11 (7) , 689-692
Open AccessHow narrow is narrow QRS in premature ventricular contractions? A novel variant of SCN5A-associated MEPPC
- 7 May 2025
- Published by Elsevier in Sleep Medicine Reviews
- Vol. 81, 102097
Diagnostic accuracy of machine learning algorithms in electrocardiogram-based sleep apnea detection: A systematic review and meta-analysis
- 7 May 2025
- Published by Elsevier in Sleep Medicine Reviews
- Vol. 81, 102097
Diagnostic accuracy of machine learning algorithms in electrocardiogram-based sleep apnea detection: A systematic review and meta-analysis
- 21 April 2025
- Published by Springer Nature in Journal of Medical and Biological Engineering
- Vol. 45 (2) , 314-324
Explainable AI for Specific Arrhythmia Detection: SHAP-Based Insights from Multi-Lead ECG Data
- 21 April 2025
- Published by Springer Nature in Journal of Medical and Biological Engineering
- Vol. 45 (2) , 314-324
Explainable AI for Specific Arrhythmia Detection: SHAP-Based Insights from Multi-Lead ECG Data
- Open Access
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (2)
Clinical Outcomes and Mortality in Patients with Implantable Cardioverter-Defibrillator for Primary Prevention
Background Implantable cardioverter-defibrillator (ICD) is indicated for primary prevention in patients with left ventricular ejection fraction (LVEF) ≤ 35% and New York Heart Association class II or III heart failure despite 3 months of optimal medical therapy. However, studies that support this recommendation are over 20 years old, and they may not reflect modern heart failure patients’ characteristics. Objectives Retrospectively evaluate patients who received an ICD for primary prevention. Methods All-cause and sudden death rates were compared in patients who received ICD between January 1, 2015 and March 1, 2020 and those who did not accept ICD. Variables were analyzed at a 95% confidence interval, and p < 0.05 was considered as significant. Results When comparing mortality rates between patients with and without ICD, 67 of 228 patients (29.4%) in the ICD group and 39 of 150 patients (26%) in the control group died from all causes (p = 0.473). Age, LVEF, BNP value, and hospitalization were found to be independent predictors of all-cause mortality. Patients with BNP above 508.5, LVEF below 24.5%, and age over 68.5 years had a 25-fold increased all-cause mortality. Coronary artery disease was not found to be an independent risk factor. Survival in the control group was statistically significantly better in the first months. Although there was no statistical difference in the long term, survival was numerically better in the ICD arm. This could be attributed to the fact that ICD implantations were performed on patients with worse clinical conditions. The higher survival rate observed in patients with ICD may be due to the fact that they came in for device control and remained in follow-up. Conclusions With advances in the treatment of heart failure, ICD implantation should be performed in selected patients.
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (2)
Open AccessClinical Outcomes and Mortality in Patients with Implantable Cardioverter-Defibrillator for Primary Prevention
Background Implantable cardioverter-defibrillator (ICD) is indicated for primary prevention in patients with left ventricular ejection fraction (LVEF) ≤ 35% and New York Heart Association class II or III heart failure despite 3 months of optimal medical therapy. However, studies that support this recommendation are over 20 years old, and they may not reflect modern heart failure patients’ characteristics. Objectives Retrospectively evaluate patients who received an ICD for primary prevention. Methods All-cause and sudden death rates were compared in patients who received ICD between January 1, 2015 and March 1, 2020 and those who did not accept ICD. Variables were analyzed at a 95% confidence interval, and p < 0.05 was considered as significant. Results When comparing mortality rates between patients with and without ICD, 67 of 228 patients (29.4%) in the ICD group and 39 of 150 patients (26%) in the control group died from all causes (p = 0.473). Age, LVEF, BNP value, and hospitalization were found to be independent predictors of all-cause mortality. Patients with BNP above 508.5, LVEF below 24.5%, and age over 68.5 years had a 25-fold increased all-cause mortality. Coronary artery disease was not found to be an independent risk factor. Survival in the control group was statistically significantly better in the first months. Although there was no statistical difference in the long term, survival was numerically better in the ICD arm. This could be attributed to the fact that ICD implantations were performed on patients with worse clinical conditions. The higher survival rate observed in patients with ICD may be due to the fact that they came in for device control and remained in follow-up. Conclusions With advances in the treatment of heart failure, ICD implantation should be performed in selected patients.